Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphoma presenting as bone marrow failure.

B Koziner, L Ellman, A C Aisenberg

    Cancer
    |May 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    The degree of lymphoma differentiation is critical for patient survival. Poorly differentiated non-Hodgkin

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Recombinant Interferon Alpha-2b in Patients with Progressive and/or Recurrent Hodgkin's Disease.

    Leukemia & lymphoma·2016
    Same author

    Masochistic pleasure.

    British dental journal·2010
    Same author

    Smell the coffee.

    British dental journal·2008
    Same author

    Bizarre assumptions.

    British dental journal·2007
    Same author

    The first Buenos Aires international workshop on cellular and molecular therapies.

    Cytotherapy·2006
    Same author

    Double-blind prospective randomized comparison of interferon gamma-1b versus placebo after autologous stem cell transplantation.

    Acta haematologica·2002
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    Same journal

    Most older patients with advanced cancer prioritize QOL over extending survival: A secondary analysis of the GAP70+ trial found that among adults aged 70 and older with advanced, noncurable cancer, nearly three-quarters prioritized maintaining QOL.

    Cancer·2026
    Same journal

    Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

    Cancer·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology

    Background:

    • Non-Hodgkin's lymphoma can cause severe leukopenia and thrombocytopenia due to bone marrow infiltration.
    • Cytopenias are common complications in lymphoma patients.

    Purpose of the Study:

    • To investigate the prognostic significance of lymphoma differentiation in patients with non-Hodgkin's lymphoma.
    • To evaluate the impact of cytopenia on survival in different lymphoma subtypes.

    Main Methods:

    • Retrospective review of 550 patients diagnosed with non-Hodgkin's lymphoma.
    • Analysis of clinical data including blood counts, lymphoma grade, and survival outcomes.

    Main Results:

    • Only 3% of patients presented with severe leukopenia or thrombocytopenia.

    Related Experiment Videos

  • Well-differentiated lymphoma correlated with a favorable prognosis, even with cytopenia.
  • Poorly differentiated lymphoma showed a median survival of only 4 months.

    • Conclusions:

    • Lymphoma differentiation is the critical factor influencing patient survival.
    • Conventional therapy is largely ineffective for poorly differentiated lymphoma.
    • Intensive multidrug chemotherapy regimens warrant investigation for poorly differentiated cases, despite cytopenia risks.